Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter

被引:10
|
作者
Pelham, Christopher [1 ]
Jimenez, Tamara [1 ]
Rodova, Marianna [1 ]
Rudolph, Angela [1 ]
Chipps, Elizabeth [1 ]
Islam, M. Rafiq [1 ]
机构
[1] NW Missouri State Univ, Biochem Lab, Maryville, MO 64468 USA
关键词
HFE; PARP1; Negative element; Inverted repeat; Cruciform; HAMP; TRANSCRIPTIONAL REPRESSION; CRUCIFORM STRUCTURES; INDUCED APOPTOSIS; IRON-ABSORPTION; DOWN-REGULATION; BINDING; GENE; MODULATION; CLEAVAGE; HEMOCHROMATOSIS;
D O I
10.1016/j.bbagrm.2013.10.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron overload among Caucasians of northern European descent. Over 85% of all cases with HH are due to mutations in the hemochromatosis protein (HFE) involved in iron metabolism. Although the importance in iron homeostasis is well recognized, the mechanism of sensing and regulating iron absorption by HFE, especially in the absence of iron response element in its gene, is not fully understood. In this report, we have identified an inverted repeat sequence (ATGGTcttACCTA) within 1700 bp (-16751+35) of the HFE promoter capable to form cruciform structure that binds PARP1 and strongly represses HFE promoter. Knockdown of PARP1 increases HFE mRNA and protein. Similarly, hemin or FeCl3 treatments resulted in increase in HFE expression by reducing nuclear PARP1 pool via its apoptosis induced cleavage, leading to upregulation of the iron regulatory hormone hepcidin mRNA. Thus, PARP1 binding to the inverted repeat sequence on the HFE promoter may serve as a novel iron sensing mechanism as increased iron level can trigger PARP1 cleavage and relief of HFE transcriptional repression. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 50 条
  • [21] Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding
    Lonskaya, I
    Potaman, VN
    Shlyakhtenko, LS
    Oussatcheva, EA
    Lyubchenko, YL
    Soldatenkov, VA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17076 - 17083
  • [22] Poly(ADP-ribose)polymerase-1 (PARP-1) expression and activity in primary human lung cells
    Ahmad, MH
    Torky, A
    Glahn, F
    Raemisch, A
    Foth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 113 - 113
  • [23] Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium
    Cooper, Karen L.
    Dashner, Erica J.
    Tsosie, Ranalda
    Cho, Young Mi
    Lewis, Johnnye
    Hudson, Laurie G.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 291 : 13 - 20
  • [24] The 3′-5′ DNA Exonuclease TREX1 Directly Interacts with Poly(ADP-ribose) Polymerase-1 (PARP1) during the DNA Damage Response
    Miyazaki, Takuya
    Kim, Yong-Soo
    Yoon, Jeongheon
    Wang, Hongsheng
    Suzuki, Teruhiko
    Morse, Herbert C., III
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (47) : 32548 - 32558
  • [25] Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity
    Bürkle, A
    Beneke, S
    Brabeck, C
    Leake, A
    Meyer, R
    Muiras, ML
    Pfeiffer, R
    EXPERIMENTAL GERONTOLOGY, 2002, 37 (10-11) : 1203 - 1205
  • [26] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 222 - 224
  • [27] Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
    Ba, Xueqing
    Garg, Nisha Jain
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (03): : 946 - 955
  • [28] PARP-1 (Poly[ADP-Ribose] Polymerase-1): A Novel Target in Aortic Aneurysm
    Alves-Lopes, Rheure
    Touyz, Rhian M.
    HYPERTENSION, 2018, 72 (05) : 1087 - 1089
  • [29] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 542 - 545
  • [30] Poly(ADP-ribose) polymerase-1 in the nervous system
    Ha, HC
    Snyder, SH
    NEUROBIOLOGY OF DISEASE, 2000, 7 (04) : 225 - 239